Nomination by the Prix Galien Foundation recognizes the AeroPace® System, the first FDA-approved diaphragm neurostimulation therapy to help critically ill patients breathe on their own again EXTON, Pa., Aug. 19, 2026 (GLOBE NEWSWIRE) — Lungpacer Medical Inc. today announced that its AeroPace System has been nominated for the 2026 Prix Galien USA Award for Best […]